Physician profile
Michael Umanoff
NPI 1902804438
$8,944.35
in general payments reported to CMS, 2019-2025
29 companies · $716 in 2025
The $716 reported for 2025 was more than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $343 · 2020: $374 · 2021: $453 · 2022: $3,750 · 2023: $1,810 · 2024: $1,498 · 2025: $716.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,968 · Travel and Lodging: $771 · Entertainment: $285.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,968.30 |
| Travel and Lodging | $771.44 |
| Entertainment | $284.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Relievant Medsystems, INC. | $2,919.22 | 2021-2023 | Intracept |
| Genesys Orthopedics Systems, L.L.C. | $2,042.15 | 2022 | |
| Foundation Fusion Solutions, LLC | $805.89 | 2021-2025 | |
| Boston Scientific Corporation | $582.87 | 2019-2025 | Intracept, Wavewriter Alpha Prime 16, Intracept Rf Probe |
| Vertos Medical, INC. | $418.42 | 2024 | Mild Device Kit |
| Collegium Pharmaceutical, INC. | $264.97 | 2019-2025 | Xtampza, Belbuca |
| Abbott Laboratories | $228.06 | 2019-2022 | |
| Spr Therapeutics, INC | $156.59 | 2022-2024 | Sprint Pns System |
| Medtronic, INC. | $151.03 | 2023-2024 | Mazor X System, Plasmablade(Tm), Aquamantys(Tm) |
| Vertiflex, INC. | $150.55 | 2019 | |
| Si-Bone, INC. | $148.43 | 2021-2022 | |
| Stryker Corporation | $147.63 | 2024 | Canyon Retractor Systems, Monterey Al |
| Spinal Elements, INC. | $104.07 | 2024 | |
| Medtronic USA, INC. | $103.45 | 2020 | |
| Augmedics INC. | $83.86 | 2024 | Xvision |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik Nro, INC. | $83.49 | 2024 | Prospera |
| Nalu Medical, INC. | $80.82 | 2024 | Nalu Neurostimulation System |
| Stimwave Technologies Incorporated | $62.50 | 2020 | |
| Saluda Medical Americas, INC. | $57.72 | 2023-2025 | Evoke, Evoke Scs |
| Scilex Pharmaceuticals INC. | $55.94 | 2022-2023 | Ztlido |
| Djo, LLC | $54.89 | 2023 | Cmf |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $47.98 | 2023-2025 | Relistor |
| Nevro Corp. | $41.67 | 2020 | |
| Allergan, INC. | $29.12 | 2019 | |
| Mml US, INC. | $28.63 | 2025 | Reactiv8 |
| Daiichi Sankyo INC. | $27.83 | 2019 | |
| Lilly USA, LLC | $24.70 | 2021-2022 | |
| Curonix LLC | $21.77 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Azurity Pharmaceuticals, INC. | $20.10 | 2023 | Gliadel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Umanoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.